ESC Premium Access

About the speakers

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)
21 presentations
0 follower

Doctor Samuel Dagogo-Jack

Memphis (United States of America)
3 presentations
0 follower

Doctor Anselm Kai Gitt

Klinikum Ludwigshafen, Ludwigshafen (Germany)
15 presentations
0 follower

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)
19 presentations
0 follower

6 more presentations in this session

Welcome and opening remarks.

Speaker: Professor D. McGuire (Dallas, US)


Diabetes takes a center stage in overall risk for patients with cardiovascular disease .

Speaker: Doctor A. Gitt (Ludwigshafen, DE)


SGLT2 Inhibitors: diabetes or cardiovascular drugs?

Speaker: Professor L. Leiter (Toronto, CA)


Ertugliflozin – A newly emerging SGLT2 inhibitor for patients with type 2 diabetes.

Speaker: Doctor S. Dagogo-Jack (Memphis, US)


Envisioning the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease: a roundtable discussion.

Speaker: Professor L. Leiter (Toronto, CA) Doctor A. Gitt (Ludwigshafen, DE) Professor D. McGuire (Dallas, US) Doctor S. Dagogo-Jack (Memphis, US)


Access the full session

Five things cardiologists should know about diabetes

Speakers: Professor D. McGuire, Doctor S. Dagogo-Jack, Doctor A. Gitt, Professor L. Leiter, Professor D. McGuire...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb